Expert Insights: Long-Term Potential of Sanofi India Shares
Market expert Chandan Taparia provides a detailed analysis and long-term view on Sanofi India shares, offering valuable advice to investors.
Sanofi IndiaStock MarketInvestmentPharmaceuticalsMarket TrendsReal Estate NewsNov 07, 2024
Sanofi India, one of the leading pharmaceutical companies in the country, has seen a significant rally of 24% in recent times. According to Chandan, the stock has the potential to reach ₹7,600 in the long term. However, to achieve this target, it is crucial that the stock stays above the ₹6,800 level. This level acts as a significant supply trendline, and maintaining it is essential for the stock to reach the anticipated ₹7,500 mark.
Chandan advises investors to hold onto their Sanofi India shares if the stock remains above ₹6,800. This strategy ensures that investors can benefit from the expected long-term appreciation. For those who are considering buying, the expert recommends entering above this support level to minimize risk.
Daily Calls is designed to help investors of all levels, from seasoned professionals to beginners. Our show offers live insights, hold, buy, and sell recommendations, and expert guidance on other promising investment opportunities in the market. Tune in from Monday to Friday, 12 pm to 1 pm, to get the latest market updates and expert advice.
Sanofi India has a strong presence in the pharmaceutical sector, with a diverse portfolio of products and a robust research and development pipeline. The company's commitment to innovation and quality has made it a trusted name in the industry. For investors looking to diversify their portfolio, pharmaceutical stocks like Sanofi India can offer both stability and growth potential.
Whether you're looking to make informed investment decisions or simply want to stay updated on the latest market trends, Daily Calls is the perfect platform. Join us for expert insights and valuable recommendations that can help you achieve your financial goals.
Frequently Asked Questions
What is the current performance of Sanofi India shares?
Sanofi India shares have rallied 24% in recent times, showing a strong upward trend.
What is the long-term target price for Sanofi India shares?
The long-term target price for Sanofi India shares, as per market expert Chandan Taparia, is ₹7,600.
What is the recommended holding level for Sanofi India shares?
Chandan Taparia advises holding Sanofi India shares above the ₹6,800 level to ensure long-term appreciation.
What is the best time to tune in for live market insights and recommendations?
You can tune in to Daily Calls from Monday to Friday, 12 pm to 1 pm, for live market insights and expert recommendations.
Why should investors consider pharmaceutical stocks like Sanofi India?
Pharmaceutical stocks like Sanofi India offer both stability and growth potential, making them a valuable addition to a diversified investment portfolio.
Related News Articles
Indian Realty Giants Unload Properties Worth Rs 1.17 Lakh Crore in FY24
Leading real estate companies in India, such as Macrotech Developers and Signature Global, have sold properties worth a staggering Rs 1.17 lakh crore in FY24.
Soaring Demand Drives Up Property Prices in Delhi-NCR and MMR
Average housing prices in Delhi-NCR and Mumbai Metropolitan Region (MMR) have risen by nearly 50% in the last five years, driven by higher demand and infrastructural developments.
Aditya Birla Real Estate: Pune Launch on the Cards, Expanding in Thane and Sarjapur
In a recent post-earnings call, the management of Aditya Birla Real Estate Ltd, formerly known as Century Textiles and Industries Ltd, announced the upcoming launch of a new project in Pune, along with plans to expand in Thane and Sarjapur.
ACRES 2025 Showcases Over 400 Property Projects in Egypt Pavilion
Organised by the Sharjah Chamber of Commerce and Industry (SCCI) in collaboration with the Sharjah Real Estate Registration Department (SRERD), the ACRES 2025 event is set to feature an extensive array of property projects from Egypt, highlighting the cou
The 23-Year Journey: How a UP Man Purchased Dawood Ibrahim’s Mumbai Shop
Hemant Jain took a significant risk in 2001 by purchasing a Mumbai shop linked to Dawood Ibrahim. Despite numerous bureaucratic obstacles, he finally managed to register the property after a grueling 23-year battle.
What Are the Top 20 Expectations for the Budget 2025-26?
As the Union Budget 2025-26 approaches, scheduled to be presented by Finance Minister Nirmala Sitharaman on February 1 (Saturday), the real estate industry and other sectors are bracing for significant changes and potential boosts. Here’s a detailed look